Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / NYLI FTSE INTERN
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
11,156,130
-
Shares change
-
-38,793
-
Total reported value, excl. options
-
$276,323,000
-
Value change
-
-$806,984
-
Number of buys
-
11
-
Number of sells
-
-18
-
Price
-
$24.77
Significant Holders of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) as of Q2 2021
33 filings reported holding HFXI - NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN as of Q2 2021.
NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,156,130 shares
.
Largest 10 shareholders include NEW YORK LIFE INVESTMENT MANAGEMENT LLC (6,355,907 shares), UBS Group AG (1,152,945 shares), BANK OF AMERICA CORP /DE/ (857,840 shares), MORGAN STANLEY (843,063 shares), Avestar Capital, LLC (397,227 shares), Raymond James Financial Services Advisors, Inc. (329,963 shares), COMMONWEALTH EQUITY SERVICES, LLC (207,228 shares), Ten Capital Wealth Advisors, LLC (187,537 shares), ROYAL BANK OF CANADA (160,928 shares), and Cambridge Investment Research Advisors, Inc. (146,854 shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.